These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
116 related items for PubMed ID: 8730181
1. Susceptibility-weighted MR for evaluation of vasodilatory capacity with acetazolamide challenge. Ohnishi T, Nakano S, Yano T, Hoshi H, Jinnouchi S, Nagamachi S, Flores L, Watanabe K, Yokogami K, Ohta H. AJNR Am J Neuroradiol; 1996 Apr; 17(4):631-7. PubMed ID: 8730181 [Abstract] [Full Text] [Related]
2. Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT. Leinsinger G, Piepgras A, Einhäupl K, Schmiedek P, Kirsch CM. AJNR Am J Neuroradiol; 1994 Aug; 15(7):1327-32. PubMed ID: 7976945 [Abstract] [Full Text] [Related]
3. The Effects of Acetazolamide on the Evaluation of Cerebral Hemodynamics and Functional Connectivity Using Blood Oxygen Level-Dependent MR Imaging in Patients with Chronic Steno-Occlusive Disease of the Anterior Circulation. Wu J, Dehkharghani S, Nahab F, Allen J, Qiu D. AJNR Am J Neuroradiol; 2017 Jan; 38(1):139-145. PubMed ID: 27758776 [Abstract] [Full Text] [Related]
4. Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. Chen A, Shyr MH, Chen TY, Lai HY, Lin CC, Yen PS. AJNR Am J Neuroradiol; 2006 Oct; 27(9):1876-81. PubMed ID: 17032859 [Abstract] [Full Text] [Related]
5. Adverse effects of intravenous acetazolamide administration for evaluation of cerebrovascular reactivity using brain perfusion single-photon emission computed tomography in patients with major cerebral artery steno-occlusive diseases. Saito H, Ogasawara K, Suzuki T, Kuroda H, Kobayashi M, Yoshida K, Kubo Y, Ogawa A. Neurol Med Chir (Tokyo); 2011 Oct; 51(7):479-83. PubMed ID: 21785240 [Abstract] [Full Text] [Related]
6. Assessment of blood flow velocity and diameter of the middle cerebral artery during the acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. Schreiber SJ, Gottschalk S, Weih M, Villringer A, Valdueza JM. AJNR Am J Neuroradiol; 2000 Aug; 21(7):1207-11. PubMed ID: 10954270 [Abstract] [Full Text] [Related]
7. Perfusion computed tomography evaluation of cerebral hemodynamic impairment in patients with unilateral chronic steno-occlusive disease: a comparison with the acetazolamide challenge 99mTc-hexamethylpropyleneamine oxime single-photon emission computed tomography. Kim E, Sohn CH, Na DG, Kim JE, Chang KH, Kim JH, Jeon SJ. J Comput Assist Tomogr; 2009 Aug; 33(4):546-51. PubMed ID: 19638847 [Abstract] [Full Text] [Related]
12. [MR angiography enhanced by sodium acetazolamide]. Araki Y, Tanaka H, Ohtani M, Yamamoto H, Yamamoto T, Tsukaguchi I. Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Nov 25; 52(11):1605-7. PubMed ID: 1465341 [Abstract] [Full Text] [Related]
13. Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N. AJNR Am J Neuroradiol; 2004 Feb 25; 25(2):242-7. PubMed ID: 14970024 [Abstract] [Full Text] [Related]
14. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease. Okazawa H, Yamauchi H, Toyoda H, Sugimoto K, Fujibayashi Y, Yonekura Y. J Nucl Med; 2003 Dec 25; 44(12):1875-83. PubMed ID: 14660711 [Abstract] [Full Text] [Related]
15. Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. Okazawa H, Yamauchi H, Sugimoto K, Toyoda H, Kishibe Y, Takahashi M. J Cereb Blood Flow Metab; 2001 Dec 25; 21(12):1472-9. PubMed ID: 11740209 [Abstract] [Full Text] [Related]
16. [Diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133Xe SPECT and acetazolamide (Diamox) test]. Kuroda S, Takigawa S, Kamiyama H, Abe H, Sakuragi M, Motomiya M, Nakagawa T, Mitsumori K, Tsuru M. No Shinkei Geka; 1990 Feb 25; 18(2):167-73. PubMed ID: 2336145 [Abstract] [Full Text] [Related]
17. Symptomatic carotid artery stenosis: impairment of cerebral autoregulation measured at the brain tissue level with arterial spin-labeling MR imaging. Bokkers RP, van Osch MJ, van der Worp HB, de Borst GJ, Mali WP, Hendrikse J. Radiology; 2010 Jul 25; 256(1):201-8. PubMed ID: 20574097 [Abstract] [Full Text] [Related]
18. Gender-related differences in acetazolamide-induced cerebral vasodilatory response: a transcranial Doppler study. Oláh L, Valikovics A, Bereczki D, Fülesdi B, Munkácsy C, Csiba L. J Neuroimaging; 2000 Jul 25; 10(3):151-6. PubMed ID: 10918741 [Abstract] [Full Text] [Related]
19. Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with (133)Xe SPECT in occlusive cerebrovascular disease. Kikuchi K, Murase K, Miki H, Yasuhara Y, Sugawara Y, Mochizuki T, Ikezoe J, Ohue S. AJR Am J Roentgenol; 2002 Jul 25; 179(1):229-35. PubMed ID: 12076942 [Abstract] [Full Text] [Related]
20. Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding. A comparison with acetazolamide as vasodilatory stimulus. Müller M, Voges M, Piepgras U, Schimrigk K. Stroke; 1995 Jan 25; 26(1):96-100. PubMed ID: 7839406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]